BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been granted approval by the Central Drugs Standard Control Organisation (CDSCO) of India to carry out its clinical trial, RelieveHFpEF-II, in the country. The RelieveHFpEF-II trial is a randomized, cross-over design, First-in-Human, Early Feasibility Study that employs BaroPace’s […]